chemotherapy
European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated non-small cell lung cancer in adult patients
August 27, 2024Research and Development J&J, Oncology, chemotherapy, non-small cell lung cancer
Today, Janssen-Cilag International, part of Johnson & Johnson (J&J) has announced that the European Comission (EC) has approved a combined …
AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment
June 25, 2024Medical Communications AstraZeneca, Oncology, Tagrisso, chemotherapy, lung cancer
AstraZeneca has announced that Tagrisso (osimertinib) in combination with pemetrexed and platinum-based chemotherapy has been approved in Japan for the …
AstraZeneca’s Imfinzi approved in US for endometrial cancer treatment
June 17, 2024Medical Communications AstraZeneca, Imfinzi, Oncology, chemotherapy, endometrial cancer
AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) in combination with carboplatin and …
Targeted chemotherapy to kill all solid tumours developed in preclinical research
August 3, 2023Research and Development Cancer, Oncology, chemotherapy, pharmaceutical, tumour
Researchers from the City of Hope organisation in the US have released a study confirming the development of AOH1996, a …
AstraZeneca announces positive results from phase 3 trial for Tagrisso plus chemotherapy
May 17, 2023Research and Development AstraZeneca, Cancer, Oncology, Tagrisso, chemotherapy
AstraZeneca has announced positive results from the FLAURA2 phase 3 trial which showed that Tagrisso (osimertinib), in combination with chemotherapy, …
Single cycle of chemo is just as effective as two in treating testicular cancer, study finds
January 3, 2020Medical Communications Cancer, Men's Cancer, chemo, chemotherapy, testicular cancer
A new study shows that testicular cancer can be successfully treated with less rounds of chemotherapy. The recent study, published …
Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma
January 21, 2019Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure
Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …
Roche’s Tecentriq+chemo combo shows first-line benefit in small cell lung cancer
September 26, 2018Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq
Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …
CHMP recommend white blood cell growth stimulator biosimilar to EMA
July 30, 2018Sales and Marketing Amgen, CHMP, EMA, Neulasta, biosimilar, chemotherapy, pegfilgrastim
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate …
Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours
March 9, 2018Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma
Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …
Novartis’ drug doubly effective as chemotherapy for treating lung cancer
December 8, 2016NSCLC, Novartis, chemotherapy
Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …
Teva’s drug to replace chemotherapy in acute leukaemia
November 21, 2016Medical Communications, Sales and Marketing Teva, chemotherapy, first line, first-line, leukaemia
Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …
New drugs to utilise DNA damage response to kill cancer cells
July 26, 2016Research and Development, Sales and Marketing AstraZeneca, Cancer, Wellcome Trust, chemotherapy, dna damage response, university of sussex
The University of Sussex is set to produce a portfolio of new cancer drugs which exploit our DNA damage response …
Midatech launch treatment to reduce chemo-induced vomiting in the US
April 11, 2016Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting
Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …
EU nod for Roche cancer drug and chemotherapy
April 8, 2015Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD
The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer. Avastin (bevacizumab) …
